Aurora Cannabis (ACB) Competitors

C$4.83 +0.06 (+1.26%)

As of 12:39 PM Eastern

ACB vs. THCX, TLRY, DHT.UN, GUD, and WEED

Should you buy Aurora Cannabis stock or one of its competitors? MarketBeat compares Aurora Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aurora Cannabis include Hydropothecary (THCX), Tilray Brands (TLRY), DRI Healthcare Trust (DHT.UN), Knight Therapeutics (GUD), and Canopy Growth (WEED). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Aurora Cannabis compare to Hydropothecary?

Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	C$373.12M	0.77	-C$44.16M	-C$1.50	N/A
Hydropothecary	N/A	N/A	N/A	N/A	N/A

4.2% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Aurora Cannabis had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Hydropothecary. Aurora Cannabis' average media sentiment score of 0.77 beat Hydropothecary's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Overall Sentiment
Aurora Cannabis	Positive
Hydropothecary	Neutral

Aurora Cannabis currently has a consensus price target of C$9.25, suggesting a potential upside of 91.51%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Hydropothecary	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -1.69%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-1.69%	-1.15%	-1.87%
Hydropothecary	N/A	N/A	N/A

Summary

Aurora Cannabis beats Hydropothecary on 7 of the 10 factors compared between the two stocks.

How does Aurora Cannabis compare to Tilray Brands?

Tilray Brands (TSE:TLRY) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Tilray Brands currently has a consensus price target of C$13.30, indicating a potential upside of 80.46%. Aurora Cannabis has a consensus price target of C$9.25, indicating a potential upside of 91.51%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts clearly believe Aurora Cannabis is more favorable than Tilray Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	1.03	-C$183.24M	-C$14.63	N/A
Aurora Cannabis	C$373.12M	0.77	-C$44.16M	-C$1.50	N/A

4.1% of Tilray Brands shares are held by institutional investors. Comparatively, 4.2% of Aurora Cannabis shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Tilray Brands and Tilray Brands both had 1 articles in the media. Aurora Cannabis' average media sentiment score of 0.77 beat Tilray Brands' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aurora Cannabis has a net margin of -1.69% compared to Tilray Brands' net margin of -158.75%. Aurora Cannabis' return on equity of -1.15% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Aurora Cannabis	-1.69%	-1.15%	-1.87%

Tilray Brands has a beta of 3.243166, suggesting that its stock price is 224% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.415152, suggesting that its stock price is 58% less volatile than the broader market.

Summary

Aurora Cannabis beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to DRI Healthcare Trust?

DRI Healthcare Trust (TSE:DHT.UN) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

In the previous week, DRI Healthcare Trust had 7 more articles in the media than Aurora Cannabis. MarketBeat recorded 8 mentions for DRI Healthcare Trust and 1 mentions for Aurora Cannabis. DRI Healthcare Trust's average media sentiment score of 1.05 beat Aurora Cannabis' score of 0.77 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DRI Healthcare Trust	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DRI Healthcare Trust has a net margin of 5.02% compared to Aurora Cannabis' net margin of -1.69%. DRI Healthcare Trust's return on equity of 2.06% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Aurora Cannabis	-1.69%	-1.15%	-1.87%

DRI Healthcare Trust has a beta of 0.347429, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.415152, suggesting that its stock price is 58% less volatile than the broader market.

0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.2% of Aurora Cannabis shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

DRI Healthcare Trust has higher earnings, but lower revenue than Aurora Cannabis. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$163.77M	5.37	C$9.73M	-C$0.90	N/A
Aurora Cannabis	C$373.12M	0.77	-C$44.16M	-C$1.50	N/A

DRI Healthcare Trust presently has a consensus target price of C$22.30, indicating a potential upside of 39.38%. Aurora Cannabis has a consensus target price of C$9.25, indicating a potential upside of 91.51%. Given Aurora Cannabis' higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than DRI Healthcare Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

DRI Healthcare Trust beats Aurora Cannabis on 10 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Knight Therapeutics has a beta of -0.214451, suggesting that its share price is 121% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.415152, suggesting that its share price is 58% less volatile than the broader market.

In the previous week, Aurora Cannabis had 1 more articles in the media than Knight Therapeutics. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Knight Therapeutics. Aurora Cannabis' average media sentiment score of 0.77 beat Knight Therapeutics' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Overall Sentiment
Knight Therapeutics	Neutral
Aurora Cannabis	Positive

Knight Therapeutics has higher revenue and earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Knight Therapeutics	C$510.45M	1.58	-C$30.73M	C$0.06	136.50
Aurora Cannabis	C$373.12M	0.77	-C$44.16M	-C$1.50	N/A

Knight Therapeutics has a net margin of 1.10% compared to Aurora Cannabis' net margin of -1.69%. Knight Therapeutics' return on equity of 0.73% beat Aurora Cannabis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Knight Therapeutics	1.10%	0.73%	0.51%
Aurora Cannabis	-1.69%	-1.15%	-1.87%

Knight Therapeutics presently has a consensus target price of C$9.50, indicating a potential upside of 16.00%. Aurora Cannabis has a consensus target price of C$9.25, indicating a potential upside of 91.51%. Given Aurora Cannabis' higher probable upside, analysts clearly believe Aurora Cannabis is more favorable than Knight Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Knight Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

23.9% of Knight Therapeutics shares are held by institutional investors. Comparatively, 4.2% of Aurora Cannabis shares are held by institutional investors. 45.6% of Knight Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Knight Therapeutics beats Aurora Cannabis on 10 of the 15 factors compared between the two stocks.

How does Aurora Cannabis compare to Canopy Growth?

Aurora Cannabis (TSE:ACB) and Canopy Growth (TSE:WEED) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

In the previous week, Aurora Cannabis and Aurora Cannabis both had 1 articles in the media. Aurora Cannabis' average media sentiment score of 0.77 beat Canopy Growth's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Canopy Growth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aurora Cannabis has a beta of 0.415152, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 1.605535, suggesting that its share price is 61% more volatile than the broader market.

Aurora Cannabis has a net margin of -1.69% compared to Canopy Growth's net margin of -117.31%. Aurora Cannabis' return on equity of -1.15% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-1.69%	-1.15%	-1.87%
Canopy Growth	-117.31%	-52.88%	-3.83%

Aurora Cannabis currently has a consensus price target of C$9.25, indicating a potential upside of 91.51%. Canopy Growth has a consensus price target of C$1.97, indicating a potential upside of 34.70%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities analysts plainly believe Aurora Cannabis is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Canopy Growth	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	C$373.12M	0.77	-C$44.16M	-C$1.50	N/A
Canopy Growth	C$278.39M	2.22	-C$1.05B	-C$1.86	N/A

4.2% of Aurora Cannabis shares are held by institutional investors. Comparatively, 3.6% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Aurora Cannabis beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACB vs. The Competition

Export

Metric	Aurora Cannabis	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$285.58M	C$2.15B	C$6.30B	C$11.94B
Dividend Yield	N/A	2.96%	2.80%	6.23%
P/E Ratio	-3.22	5.39	20.79	37.37
Price / Sales	0.77	1,674.83	518.79	11.43
Price / Cash	1.25	10.18	43.18	82.29
Price / Book	0.48	10.43	9.96	4.39
Net Income	-C$44.16M	C$20.70B	C$3.54B	C$299.09M
7 Day Performance	5.00%	-0.91%	-0.19%	-1.22%
1 Month Performance	-1.02%	-4.03%	-0.63%	0.69%
1 Year Performance	-33.01%	23.31%	34.10%	53.47%

Aurora Cannabis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACB Aurora Cannabis	1.9676 of 5 stars	C$4.83 +1.3%	C$9.25 +91.5%	-35.7%	C$285.58M	C$373.12M	N/A	1,073
THCX Hydropothecary	N/A	C$5.30 +6.6%	N/A	+0.0%	C$949.11M	N/A	N/A	N/A	High Trading Volume
TLRY Tilray Brands	1.2775 of 5 stars	C$7.40 -2.1%	C$13.30 +79.7%	+17.8%	C$885.07M	C$858.28M	N/A	2,650
DHT.UN DRI Healthcare Trust	2.9104 of 5 stars	C$15.88 -0.1%	C$18.88 +18.9%	+25.8%	C$873.67M	C$153.37M	N/A	N/A	Positive News Analyst Forecast
GUD Knight Therapeutics	1.1596 of 5 stars	C$8.62 -0.5%	C$9.50 +10.2%	+41.8%	C$846.93M	C$510.45M	143.67	725

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:ACB) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aurora Cannabis (ACB) Competitors

ACB vs. THCX, TLRY, DHT.UN, GUD, and WEED

How does Aurora Cannabis compare to Hydropothecary?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Summary

How does Aurora Cannabis compare to DRI Healthcare Trust?

Summary

How does Aurora Cannabis compare to Knight Therapeutics?

Summary

How does Aurora Cannabis compare to Canopy Growth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aurora Cannabis (ACB) Competitors

ACB vs. THCX, TLRY, DHT.UN, GUD, and WEED

How does Aurora Cannabis compare to Hydropothecary?

Which has better valuation & earnings, ACB or THCX?

Do insiders and institutionals have more ownership in ACB or THCX?

Does the media refer more to ACB or THCX?

Do analysts prefer ACB or THCX?

Is ACB or THCX more profitable?

Summary

How does Aurora Cannabis compare to Tilray Brands?

Do analysts recommend TLRY or ACB?

Which has stronger earnings & valuation, TLRY or ACB?

Do insiders and institutionals believe in TLRY or ACB?

Does the media favor TLRY or ACB?

Is TLRY or ACB more profitable?

Which has more risk & volatility, TLRY or ACB?

Summary

How does Aurora Cannabis compare to DRI Healthcare Trust?

Does the media favor DHT.UN or ACB?

Is DHT.UN or ACB more profitable?

Which has more risk and volatility, DHT.UN or ACB?

Do institutionals & insiders believe in DHT.UN or ACB?

Which has better valuation & earnings, DHT.UN or ACB?

Do analysts recommend DHT.UN or ACB?

Summary

How does Aurora Cannabis compare to Knight Therapeutics?

Which has more risk & volatility, GUD or ACB?

Does the media refer more to GUD or ACB?

Which has stronger earnings & valuation, GUD or ACB?

Is GUD or ACB more profitable?

Do analysts prefer GUD or ACB?

Do insiders and institutionals believe in GUD or ACB?

Summary

How does Aurora Cannabis compare to Canopy Growth?

Does the media favor ACB or WEED?

Which has more risk & volatility, ACB or WEED?

Is ACB or WEED more profitable?

Do analysts recommend ACB or WEED?

Which has higher valuation & earnings, ACB or WEED?

Do institutionals and insiders hold more shares of ACB or WEED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACB vs. The Competition

Aurora Cannabis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools